Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Johnson & Johnson › Parul Doshi
PD

Parul Doshi — 12 Patents

Johnson & Johnson: 11 patents #921 of 7,810Top 15%
TCTufts Medical Center: 2 patents #16 of 73Top 25%
SUSugen: 1 patents #75 of 125Top 60%
PHPharmacia: 1 patents #961 of 1,582Top 65%
Chester Springs, PA: #31 of 227 inventorsTop 15%
Pennsylvania: #6,679 of 74,527 inventorsTop 9%
Overall (All Time): #396,045 of 4,157,543Top 10%
12 Patents All Time
Parul Doshi has been granted 12 US patents while listed as an inventor at Johnson & Johnson. The first was granted in 2008 and the most recent in April 2025. Parul Doshi ranks #396,045 of 4,157,543 US inventors in our database (top 9.5%). Patent records list Parul Doshi in Chester Springs, PA, US.

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12286474 Anti-CD38 antibodies for treatment of acute myeloid leukemia Gwenn Danet-Desnoyers, Cedric Dos Santos, Amy Sasser, Xiaochuan Shan 2025-04-29
12091466 Anti-CD38 antibodies for treatment of light chain amyloidosis and other CD38-positive hematological malignancies Chakra Chaulagain, Raymond Comenzo, Xun Ma, Amy Sasser 2024-09-17 $427,759,000
12060432 Combination therapies with anti-CD38 antibodies — 2024-08-13 $319,663,000
11713355 Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia — 2023-08-01 $341,402,000
10800851 Combination therapies with anti-CD38 antibodies — 2020-10-13 $181,688,000
10793630 Anti-CD38 antibodies for treatment of acute myeloid leukemia Gwenn Danet-Desnoyers, Cedric Dos Santos, Amy Sasser, Xiaochuan Shan 2020-10-06 $145,954,000
10766965 Anti-CD38 antibodies for treatment of light chain amyloidosis and other CD38-positive hematological malignancies Chakra Chaulagain, Raymond Comenzo, Xun Ma, Amy Sasser 2020-09-08 $121,118,000
10668149 Combination therapies for heme malignancies with anti-CD38 antibodies and survivin inhibitors Henk Lokhorst, Tuna Mutis 2020-06-02 $119,685,000
10556961 Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia — 2020-02-11 $118,021,000
9732154 Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia — 2017-08-15 $72,986,000
9603927 Combination therapies with anti-CD38 antibodies — 2017-03-28 $74,801,000
7320996 Indolinone protein kinase inhibitors and cyclooxygenase inhibitors for use in combination therapy for the treatment of cancer Jaime Masferrer, Julie Cherrington 2008-01-22

Nearby-Ranked Inventors

John Patrick Hickey, III12
Gregory Lutter12
Josselin Xavier COUPARD12
Xuan Li12
Nandana Mihindukulasooriya12
Keiichi Matsuda12
Robert Imig12
Peter Mage12
Sze Ping Ching12